Transcriptomic profiling has identified at least 5 breast cancer subtypes, including human epidermal growth factor receptor 2–positive (HER2+), luminal A, luminal B, normal-like, and basal-like breast cancer (1, 2). Here, ERBB2 is linked to breast carcinoma.